311 related articles for article (PubMed ID: 33824928)
1. The acute hepatic porphyrias.
Wang B
Transl Gastroenterol Hepatol; 2021; 6():24. PubMed ID: 33824928
[TBL] [Abstract][Full Text] [Related]
2. Acute Hepatic Porphyrias: Review and Recent Progress.
Wang B; Rudnick S; Cengia B; Bonkovsky HL
Hepatol Commun; 2019 Feb; 3(2):193-206. PubMed ID: 30766957
[TBL] [Abstract][Full Text] [Related]
3. Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives.
Marcacci M; Ricci A; Cuoghi C; Marchini S; Pietrangelo A; Ventura P
Orphanet J Rare Dis; 2022 Apr; 17(1):160. PubMed ID: 35392955
[TBL] [Abstract][Full Text] [Related]
4. Acute Hepatic Porphyrias: "Purple Flags"-Clinical Features That Should Prompt Specific Diagnostic Testing.
Anderson KE; Desnick RJ; Stewart MF; Ventura P; Bonkovsky HL
Am J Med Sci; 2022 Jan; 363(1):1-10. PubMed ID: 34606756
[TBL] [Abstract][Full Text] [Related]
5. Case-based discussion of the acute hepatic porphyrias: Updates on pathogenesis, diagnosis and management.
Balwani M; Keel S; Meissner P; Sonderup M; Stein P; Yasuda M
Liver Int; 2024 Apr; ():. PubMed ID: 38618923
[TBL] [Abstract][Full Text] [Related]
6. Biochemical Diagnosis of Acute Hepatic Porphyria: Updated Expert Recommendations for Primary Care Physicians.
Anderson KE; Lobo R; Salazar D; Schloetter M; Spitzer G; White AL; Young RM; Bonkovsky HL; Frank EL; Mora J; Tortorelli S
Am J Med Sci; 2021 Aug; 362(2):113-121. PubMed ID: 33865828
[TBL] [Abstract][Full Text] [Related]
7. RNAi therapy with givosiran significantly reduces attack rates in acute intermittent porphyria.
Sardh E; Harper P
J Intern Med; 2022 May; 291(5):593-610. PubMed ID: 35067977
[TBL] [Abstract][Full Text] [Related]
8. Porphyria: What Is It and Who Should Be Evaluated?
Edel Y; Mamet R
Rambam Maimonides Med J; 2018 Apr; 9(2):. PubMed ID: 29553924
[TBL] [Abstract][Full Text] [Related]
9. An Overview of Acute Hepatic Porphyrias: Clinical Implications, Diagnostic Approaches, and Management Strategies.
Zübarioğlu T; Kıykım E; Aktuğlu-Zeybek Ç
Turk Arch Pediatr; 2023 Jan; 58(1):3-9. PubMed ID: 36598205
[TBL] [Abstract][Full Text] [Related]
10. Acute hepatic porphyrias: Recommendations for diagnosis and management with real-world examples.
Moghe A; Dickey A; Erwin A; Leaf RK; O'Brien A; Quigley JG; Thapar M; Anderson KE
Mol Genet Metab; 2023 Nov; 140(3):107670. PubMed ID: 37542766
[TBL] [Abstract][Full Text] [Related]
11. Novel treatment options for acute hepatic porphyrias.
Wang B
Curr Opin Gastroenterol; 2021 May; 37(3):194-199. PubMed ID: 33769375
[TBL] [Abstract][Full Text] [Related]
12. RNA interference therapy in acute hepatic porphyrias.
Yasuda M; Keel S; Balwani M
Blood; 2023 Nov; 142(19):1589-1599. PubMed ID: 37027823
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of acute attacks, chronic symptoms, and long-term complications among patients with acute hepatic porphyria in Japan: a real-world claims database study.
Horie Y; Yasuoka Y; Adachi T
Orphanet J Rare Dis; 2023 Dec; 18(1):384. PubMed ID: 38066651
[TBL] [Abstract][Full Text] [Related]
14. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks.
Sardh E; Harper P; Andersson DE; Floderus Y
Eur J Intern Med; 2009 Mar; 20(2):201-7. PubMed ID: 19327613
[TBL] [Abstract][Full Text] [Related]
15. Disease burden in patients with acute hepatic porphyria: experience from the phase 3 ENVISION study.
Wang B; Ventura P; Takase KI; Thapar M; Cassiman D; Kubisch I; Liu S; Sweetser MT; Balwani M
Orphanet J Rare Dis; 2022 Aug; 17(1):327. PubMed ID: 36028858
[TBL] [Abstract][Full Text] [Related]
16. Neurofilament light chain as a biomarker for acute hepatic porphyrias.
Sgobbi P; Serrano PL; Badia BML; Farias IB; de Oliveira HB; Barbosa AS; Pereira CA; Moreira VF; Pinto ÍFN; Oliveira ASB; Pinto WBVR
Front Neurol; 2024; 15():1384678. PubMed ID: 38715693
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Undiagnosed Acute Hepatic Porphyria in Cyclic Vomiting Syndrome and Overlap in Clinical Symptoms.
Cheng S; Yu E; Garacci Z; Erwin AL; Venkatesan T
Dig Dis Sci; 2023 May; 68(5):2107-2114. PubMed ID: 36380150
[TBL] [Abstract][Full Text] [Related]
18. Update on the diagnosis and management of the autosomal dominant acute hepatic porphyrias.
Schulenburg-Brand D; Stewart F; Stein P; Rees D; Badminton M
J Clin Pathol; 2022 May; ():. PubMed ID: 35584894
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of Neuronal Damage in Acute Hepatic Porphyrias.
Ricci A; Di Pierro E; Marcacci M; Ventura P
Diagnostics (Basel); 2021 Nov; 11(12):. PubMed ID: 34943446
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs).
Bonkovsky HL; Dixon N; Rudnick S
Mol Genet Metab; 2019 Nov; 128(3):213-218. PubMed ID: 30987916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
